103 related articles for article (PubMed ID: 28865104)
1. Developing a quality-of-life questionnaire for oral submucous fibrosis patients.
Rai A
J Oral Pathol Med; 2017 Nov; 46(10):1054-1055. PubMed ID: 28865104
[No Abstract] [Full Text] [Related]
2. Development and validation of oral health-related quality of life measure in oral submucous fibrosis.
Gondivkar SM; Bhowate RR; Gadbail AR; Gaikwad RN; Gondivkar RS; Sarode SC; Sarode GS
Oral Dis; 2018 Sep; 24(6):1020-1028. PubMed ID: 29570905
[TBL] [Abstract][Full Text] [Related]
3. Validity of Chronic Oral Mucosal Diseases Questionnaire in oral submucous fibrosis.
Sansare K; Kapoor R; Karjodkar F
Clin Oral Investig; 2019 Feb; 23(2):873-877. PubMed ID: 29948274
[TBL] [Abstract][Full Text] [Related]
4. Impact of oral submucous fibrosis on oral health-related quality of life: A condition-specific OHRQoL-OSF instrument analysis.
Gondivkar SM; Bhowate RR; Gadbail AR; Gondivkar RS; Sarode SC; Sarode GS; Patil S
Oral Dis; 2018 Nov; 24(8):1442-1448. PubMed ID: 29928774
[TBL] [Abstract][Full Text] [Related]
5. Validation of Nepalese Oral Health Impact Profile14 and Assessment of Its Impact in Patients with Oral Submucous Fibrosis in Nepal.
Rimal J; Shrestha A
J Nepal Health Res Counc; 2015; 13(29):43-9. PubMed ID: 26411712
[TBL] [Abstract][Full Text] [Related]
6. Assessment of oral health-related quality of life instruments for oral submucous fibrosis: A systematic review using the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist.
Gondivkar SM; Bhowate RR; Gadbail AR; Sarode SC; Gondivkar RS
Oral Oncol; 2019 Jun; 93():39-45. PubMed ID: 31109694
[TBL] [Abstract][Full Text] [Related]
7. Impact of oral potentially malignant disorders on quality of life.
Tadakamadla J; Kumar S; Lalloo R; Gandhi Babu DB; Johnson NW
J Oral Pathol Med; 2018 Jan; 47(1):60-65. PubMed ID: 28766765
[TBL] [Abstract][Full Text] [Related]
8. Quality of Life-related "Patient-reported Outcome Measures" in Oral Submucous Fibrosis Patients.
Gondivkar SM; Bhowate RR; Gadbail AR; Sarode SC; Gondivkar RS; Yuwanati M; Patil S
J Contemp Dent Pract; 2018 Mar; 19(3):331-338. PubMed ID: 29603708
[TBL] [Abstract][Full Text] [Related]
9. Impact of socioeconomic inequalities on quality of life in oral submucous fibrosis patients.
Gondivkar SM; Bhowate RR; Gadbail AR; Gondivkar RS; Sarode SC
Future Oncol; 2019 Mar; 15(8):875-883. PubMed ID: 30669879
[TBL] [Abstract][Full Text] [Related]
10. Oral health-related quality of life among male subjects with oral submucous fibrosis in a tertiary care hospital.
Jena AK; Rautray S; Mohapatra M; Singh S
Indian J Public Health; 2018; 62(4):271-276. PubMed ID: 30539888
[TBL] [Abstract][Full Text] [Related]
11. Physiotherapeutic treatment improves oral opening in oral submucous fibrosis.
Cox S; Zoellner H
J Oral Pathol Med; 2009 Feb; 38(2):220-6. PubMed ID: 18673417
[TBL] [Abstract][Full Text] [Related]
12. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.
Yang PY; Chen YT; Wang YH; Su NY; Yu HC; Chang YC
J Oral Pathol Med; 2017 Nov; 46(10):1040-1045. PubMed ID: 28295637
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric morbidity among patients with oral submucous fibrosis: a controlled study.
Raja JV; Rai P; Kumar NC; Khan M; Chandrashekar H
Oral Health Dent Manag; 2013 Jun; 12(2):85-94. PubMed ID: 23756424
[TBL] [Abstract][Full Text] [Related]
15. Limited mouth opening in oral submucous fibrosis: reasons, ramifications, and remedies.
Sharma M; Radhakrishnan R
J Oral Pathol Med; 2017 Jul; 46(6):424-430. PubMed ID: 27743497
[TBL] [Abstract][Full Text] [Related]
16. Changes in prevalence of precancerous oral submucous fibrosis from 1996 to 2013 in Taiwan: A nationwide population-based retrospective study.
Yang SF; Wang YH; Su NY; Yu HC; Wei CY; Yu CH; Chang YC
J Formos Med Assoc; 2018 Feb; 117(2):147-152. PubMed ID: 28390753
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric morbidity among patients with oral sub-mucous fibrosis: a preliminary study.
Mubeen K; Kumar CN; Puja R; Jigna VR; Chandrashekar H
J Oral Pathol Med; 2010 Nov; 39(10):761-4. PubMed ID: 20923447
[TBL] [Abstract][Full Text] [Related]
18. High frequencies of vitamin B12 and folic acid deficiencies and gastric parietal cell antibody positivity in oral submucous fibrosis patients.
Wang YP; Wu YC; Cheng SJ; Chen HM; Sun A; Chang JY
J Formos Med Assoc; 2015 Sep; 114(9):813-9. PubMed ID: 26094182
[TBL] [Abstract][Full Text] [Related]
19. Morphometric evaluation of soft palate in oral submucous fibrosis--a digital cephalometric study.
Shankar VN; Hegde K; Ashwini NS; Praveena V; Ravi Prakash SM
J Craniomaxillofac Surg; 2014 Jan; 42(1):48-52. PubMed ID: 23523556
[TBL] [Abstract][Full Text] [Related]
20. Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis.
Xu C; Zhao J; Loo WT; Hao L; Wang M; Cheung MN; Dou Y; Yip AY; Ng EL; Chow LW; Liu Q
Int J Biol Markers; 2012 Dec; 27(4):e314-21. PubMed ID: 23250779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
